secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACADIA PHARMACEUTICALS INC (ACAD)
CIK:        0001070494
Form:       8-K
Filed at:   2026-01-13T23:59:59+00:00
Accession:  0001193125-26-011706
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acadia Pharmaceuticals reaffirms 2025 net sales guidance above $1B
------------------------------------------------------------------

- Anticipates 2025 net sales will exceed $1 billion, consistent with prior guidance.
- Presented at J.P. Morgan Healthcare Conference on January 13, 2026.
- Corporate slide presentation posted on ir.acadia.com for investor access.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070494/000119312526011706/0001193125-26-011706-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070494/000119312526011706/acad-20260113.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-011706

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer